Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf O Bechstein

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Transplantation Research|July 3, 2013
Extended pancreas donor program - the EXPAND study rationale and study protocolAndrea Proneth, Andreas A Schnitzbauer, Florian Zeman, et al.
The British Journal of Surgery|April 25, 2024
Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohortRemon Korenblik, Jan Heil, Jens Smits, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 23, 2013
Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literatureGiulia Manzini, Michael Kremer, Philipp Houben, et al.
Cancer Discovery|July 25, 2023
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy ResponsesHenner F Farin, Mohammed H Mosa, Benardina Ndreshkjana, et al.
The Lancet. Oncology|October 26, 2016
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trialSalah-Eddin Al-Batran, Ralf D Hofheinz, Claudia Pauligk, et al.
BMC Cancer|December 29, 2017
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGISalah-Eddin Al-Batran, Thorsten O Goetze, Daniel W Mueller, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 23, 2021
The rate of cholangiocarcinoma in Caroli Disease A German multicenter studyMohammad H Fard-Aghaie, Georgios Makridis, Tim Reese, et al.
Transplantation|October 26, 2016
Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant RegistryMarek Krawczyk, Michał Grąt, Rene Adam, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Transplantation|July 26, 2019
Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension StudyRené Adam, Vincent Karam, Valérie Cailliez, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Transplantation Research|July 3, 2013
Extended pancreas donor program - the EXPAND study rationale and study protocolAndrea Proneth, Andreas A Schnitzbauer, Florian Zeman, et al.
The British Journal of Surgery|April 25, 2024
Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohortRemon Korenblik, Jan Heil, Jens Smits, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 23, 2013
Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literatureGiulia Manzini, Michael Kremer, Philipp Houben, et al.
Cancer Discovery|July 25, 2023
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy ResponsesHenner F Farin, Mohammed H Mosa, Benardina Ndreshkjana, et al.
The Lancet. Oncology|October 26, 2016
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trialSalah-Eddin Al-Batran, Ralf D Hofheinz, Claudia Pauligk, et al.
BMC Cancer|December 29, 2017
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGISalah-Eddin Al-Batran, Thorsten O Goetze, Daniel W Mueller, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 23, 2021
The rate of cholangiocarcinoma in Caroli Disease A German multicenter studyMohammad H Fard-Aghaie, Georgios Makridis, Tim Reese, et al.
Transplantation|October 26, 2016
Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant RegistryMarek Krawczyk, Michał Grąt, Rene Adam, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Transplantation|July 26, 2019
Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension StudyRené Adam, Vincent Karam, Valérie Cailliez, et al.
Pageof 15